Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-06-16

FDA Approved: LAMOTRIGINE KIT — Supplemental Application (OWP Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Lamotrigine Kit from OWP Pharmaceuticals, Inc., enabling its marketing as a lamotrigine-based product. Lamotrigine i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lamotrigine Kit (Lamotrigine)

Snippet

SUPPL AP for LAMOTRIGINE KIT (LAMOTRIGINE)